Taurine synthesis, production and utility as a medicine

C - Chemistry – Metallurgy – 07 – C

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07C 303/02 (2006.01) A61K 31/145 (2006.01)

Patent

CA 2593563

The quantitatively most important pathway for the excretion of cholesterol in mammals is the formation of bile salts (the conjugate bases of bile acids). The major bile salts are synthesized and secreted by as glycine or taurine conjugates. Taurine (2 aminoethyl sulphonic acid) is naturally produced by the liver cells and central nervous system cells, it is neuroprotective and is a cholesterol lowering agent with virtually no recorded side effects.

La voie la plus importante, du point de vue quantitatif, d'excrétion du cholestérol chez les mammifères est la formation de sels biliaires (bases conjuguées des acides biliaires). La plupart des sels biliaires sont synthétisés et sécrétés sous forme de conjugués de glycine ou de taurine. La taurine (acide 2 aminoéthyl sulphonique), qui est produite naturellement par les cellules hépatiques et les cellules du système nerveux central, est neuroprotectrice et constitue un hypocholestérolémiant pratiquement dépourvu d'effets secondaires.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Taurine synthesis, production and utility as a medicine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Taurine synthesis, production and utility as a medicine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Taurine synthesis, production and utility as a medicine will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1462502

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.